Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine for Treatment Resistant Late-Life Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02556606

Organisation Name: VA Office of Research and Development

Overal Status: Completed

Start Date: October 1, 2015

Last Update: August 9, 2021

Lead Sponsor: VA Office of Research and Development

Brief Summary: The purpose of this study is to examine the effectiveness of a single infusion of ketamine (KET), to determine which dose is optimal 7 days after infusion using Bayesian Adaptive Randomization, and to learn about how ketamine works in the body and brain in persons with late-life treatment resistant depression.

Conditions:
  • Treatment Resistant Depressive Disorder


Total execution time in seconds: 0.22205305099487